2.84
Schlusskurs vom Vortag:
$2.79
Offen:
$2.8
24-Stunden-Volumen:
34,100
Relative Volume:
0.23
Marktkapitalisierung:
$6.80M
Einnahmen:
$1.23M
Nettoeinkommen (Verlust:
$-8.26M
KGV:
-0.7332
EPS:
-3.8732
Netto-Cashflow:
$-14.65M
1W Leistung:
+4.80%
1M Leistung:
+5.58%
6M Leistung:
-23.86%
1J Leistung:
-51.62%
Sintx Technologies Inc Stock (SINT) Company Profile
Firmenname
Sintx Technologies Inc
Sektor
Branche
Telefon
801-839-3516
Adresse
1885 WEST 2100 STREET, SALT LAKE CITY, UT
Vergleichen Sie SINT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SINT
Sintx Technologies Inc
|
2.84 | 6.80M | 1.23M | -8.26M | -14.65M | -3.8732 |
![]()
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Sintx Technologies Inc Stock (SINT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2019-09-12 | Eingeleitet | Ascendiant Capital Markets | Buy |
Sintx Technologies Inc Aktie (SINT) Neueste Nachrichten
Sintx Technologies (NASDAQ:SINT) Price Target Lowered to $28.00 at Ascendiant Capital Markets - Defense World
SINTX Technologies (SINT) Rating Maintained as Price Target Adju - GuruFocus
SINTX Technologies (SINT) Rating Maintained as Price Target Adjusted | SINT Stock News - GuruFocus
Ascendiant cuts SINTX Tech price target to $28, keeps Buy rating - Investing.com
Sintx Technologies Draws Heavy Retail Buzz On New Patent Push, Subsidiary - MSN
Sintx Technologies Draws Heavy Retail Buzz On New Patent Push, Subsidiary By Stocktwits - Investing.com India
SINTX Technologies expands into agribiotech with new patent - Investing.com Australia
SINTX Technologies expands into agribiotech with new patent By Investing.com - Investing.com South Africa
SINTX Technologies Receives Patent for Antimicrobial Agribiotech Product - mg Magazine
SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market - Koreabizwire
SINTX (SINT) Expands into Agribiotech with New Patent and Subsid - GuruFocus
SINTX Technologies, Inc. Launches Agribiotech Subsidiary Following International Patent Issuance for Silicon Nitride Applications in Agriculture - Nasdaq
SINTX Technologies Announces Patent Issuance and Formation - GlobeNewswire
This Penny Stock Is Surging on Patent News. Analysts Think It Gain 1,300% From Here. - The Globe and Mail
SINTX Technologies Inc reports results for the quarter ended March 31Earnings Summary - TradingView
SINTX Technologies refocuses on medical device market By Investing.com - Investing.com Nigeria
SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization - GlobeNewswire
SINTX Technologies (SINT) Advances as a Medical Device Innovator - GuruFocus
SINTX Technologies refocuses on medical device market - Investing.com
SINTX Technologies (SINT) Advances as a Medical Device Innovator | SINT Stock News - GuruFocus
SINTX Technologies Provides Business Update Highlighting Strateg - GuruFocus
SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization | SINT Stock News - GuruFocus
SINTX Technologies, Inc. Updates Investors on Strategic Shift to Medical Device Market and Financial Position for Q1 2025 - Nasdaq
Sintx Technologies, Inc. SEC 10-Q Report - TradingView
Sintx technologies director Mark Anderson purchases $11,800 in stock By Investing.com - Investing.com Nigeria
Sintx technologies director Mark Anderson purchases $11,800 in stock - Investing.com
Sintx Technologies (SINT) Expected to Announce Quarterly Earnings on Monday - Defense World
Sintx Technologies (SINT) Projected to Post Earnings on Monday - The AM Reporter
SINTX Technologies Inc expected to post a loss of 75 cents a shareEarnings Preview - TradingView
Renaissance Technologies LLC Purchases Shares of 21,900 Sintx Technologies, Inc. (NASDAQ:SINT) - Defense World
Sintx Technologies Approves New Executive Agreements - TipRanks
SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial - SDx Central
Sintx technologies chief strategy officer buys $7,160 in stock By Investing.com - Investing.com India
Sintx technologies chief strategy officer buys $7,160 in stock - Investing.com
Sintx Technologies, Inc. (NASDAQ:SINT) Sees Significant Increase in Short Interest - Defense World
Sintx technologies’ chief strategy officer acquires $17,666 in stock By Investing.com - Investing.com South Africa
Sintx technologies’ chief strategy officer acquires $17,666 in stock - Investing.com Australia
Sintx technologies CEO Eric Olson buys $28,087 in stock - Investing.com
Sintx Technologies Executives Increase Holdings - TradingView
Sintx Technologies (NASDAQ:SINT) Given New $30.00 Price Target at Ascendiant Capital Markets - Defense World
Sintx Technologies Appoints Five New Board Directors - TipRanks
SINT stock touches 52-week low at $2 amid market challenges - Investing.com
SINT stock touches 52-week low at $2 amid market challenges By Investing.com - Investing.com South Africa
SINTX Technologies reshapes board for medical market growth By Investing.com - Investing.com South Africa
SINTX Technologies Announces Strategic Changes to Board of Directors - Ortho Spine News
SINTX Technologies reshapes board for medical market growth - Investing.com Australia
Sintx Technologies Announces Strategic Changes To Board Of Directors - MarketScreener
Finanzdaten der Sintx Technologies Inc-Aktie (SINT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sintx Technologies Inc-Aktie (SINT) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Honigblum Gregg R. | Chief Strategy Officer |
Apr 22 '25 |
Buy |
1.79 |
4,000 |
7,160 |
14,000 |
Olson Eric K. | President and CEO |
Apr 23 '25 |
Buy |
1.94 |
14,264 |
27,680 |
14,500 |
Olson Eric K. | President and CEO |
Apr 22 '25 |
Buy |
1.73 |
236 |
408 |
236 |
Honigblum Gregg R. | Chief Strategy Officer |
Apr 22 '25 |
Buy |
1.77 |
10,000 |
17,666 |
10,000 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):